Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ADAPTIMMUNE THERAPEUTICS PLC

(ADAP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 601126834555--
Entreprise Value (EV)1 601126834555555555
P/E ratio -5,99x-0,91x-5,99x-3,58x-3,32x-4,10x
Yield ------
Capitalization / Revenue 10,1x112x211x212x30,5x5,16x
EV / Revenue 10,1x112x211x212x30,5x5,16x
EV / EBITDA -8,06x---3,80x-6,15x3,59x
Price to Book ------
Nbr of stocks (in thousands) 104 570105 166154 779155 497--
Reference price (USD) 5,751,205,393,573,573,57
Announcement Date 02/27/201902/27/202002/25/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 59,51,123,962,6118,2108
EBITDA1 -74,6---146-90,2154
Operating profit (EBIT)1 -82,4-140-133-160-168-178
Operating Margin -138%-12 457%-3 371%-6 137%-924%-165%
Pre-Tax Profit (EBT)1 --137-130-159-182-161
Net income1 -95,5-137-130-159-182-161
Net margin -161%-12 225%-3 287%-6 090%-1 002%-150%
EPS2 -0,96-1,32-0,90-1,00-1,08-0,87
Dividend per Share2 ------
Announcement Date 02/27/201902/27/202002/25/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 1,191,500,430,380,500,55
EBITDA ------
Operating profit (EBIT)1 -35,9-37,5-37,9-39,3-41,8-43,3
Operating Margin -3 007%-2 498%-8 730%-10 251%-8 359%-7 876%
Pre-Tax Profit (EBT)1 -35,4-36,6-37,5-38,6-40,4-42,2
Net income1 -35,4-36,6-37,8-38,7-40,5-42,3
Net margin -2 970%-2 438%-8 701%-10 083%-8 100%-7 682%
EPS2 -0,24-0,24-0,24-0,24-0,25-0,26
Dividend per Share ------
Announcement Date 11/05/202002/25/202105/06/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 -108-114-55,9-166-164-170
ROE (Net Profit / Equities) -42,5%---52,3%-39,4%46,5%
Shareholders' equity1 225--305463-347
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share -1,07-----
Capex1 3,911,592,341,20--
Capex / Sales 6,57%142%59,1%45,9%--
Announcement Date 02/27/201902/27/202002/25/2021---
1 USD in Million
Key data
Capitalization (USD) 555 125 789
Net sales (USD) 3 958 000
Number of employees 462
Sales / Employee (USD) 8 567
Free-Float 7,23%
Free-Float capitalization (USD) 40 162 500
Avg. Exchange 20 sessions (USD) 1 912 832
Average Daily Capital Traded 0,34%
EPS & Dividend